Oncology

Latest News

CureCancer | Image Credit: © MMPhoto21-sotck.adobe.com
COA 2025: Insight, Innovation, and Independent Strength

May 5th 2025

The 2025 Community Oncology Conference empowered attendees with insights on advocacy, innovation, and practical strategies for enhancing community cancer care.

COA logo | Image Credit: © Amy Kinnamon
Community Oncology Reacts to Trump's Drug Pricing Executive Order

May 2nd 2025

Melanoma & Skin Cancer Awareness Month | Image credit: Waseem Ali Khan - stock.adobe.com
5 Things You Should Know About Skin Cancer

May 2nd 2025

stethoscopewithcompass | Image Credit: © Talaj-stock.adobe.com
Patient Navigation Is Nonnegotiable in Cancer Care

May 1st 2025

Liver cancer - Sebastian Kaulitzki - stock.adobe.com.jpg
Elevated HLA-G Seen in HCC Driven by Viral Infections, Fatty Liver

May 1st 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Researchers Identify New Gene That Predisposes People to ALL
April 30th 2018

Researchers Identify New Gene That Predisposes People to ALL

Laura Joszt, MA
Researchers have identified a new gene that may predispose individuals to develop acute lymphoblastic leukemia (ALL). In addition, variants in the gene can influence patient response to treatment.
Former Ambassador Nancy Brinker on Bringing the Breast Cancer Conversation to the Forefront
April 29th 2018

Former Ambassador Nancy Brinker on Bringing the Breast Cancer Conversation to the Forefront

Former Ambassador Nancy Brinker, founder of Susan G. Komen, talks about the stigma that used to surround breast cancer and how she brought awareness to the disease.
Gender Disparity in Cancer Genetic Testing Influenced by Men With HBOC Risk
April 28th 2018

Gender Disparity in Cancer Genetic Testing Influenced by Men With HBOC Risk

Jaime Rosenberg
Men are 3 times less likely to receive cancer genetic testing, owing largely to hereditary breast and ovarian cancer testing.
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
April 27th 2018

Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team

Mark Soberman, MD, MBA, FACS, explains why he chose to focus on creating the next generation multidisciplinary team in cancer care during his 1-year tenure as president of the Association of Community Cancer Centers (ACCC).
Dr Victoria Bae-Jump on Challenges in Treating Patients With Endometrial Cancer
April 27th 2018

Dr Victoria Bae-Jump on Challenges in Treating Patients With Endometrial Cancer

I think the hardest thing about advanced and recurrent endometrial cancer is that the outcomes are still fairly poor, explained Victoria Bae-Jump, MD, PhD, associate professor, gynecologic oncology, University of North Carolina Lineberger Comprehensive Cancer Center.
Pulmonary Function Test Can Predict Risk of Pneumonitis in Patients With NSCLC on Chemoradiotherapy
April 26th 2018

Pulmonary Function Test Can Predict Risk of Pneumonitis in Patients With NSCLC on Chemoradiotherapy

Surabhi Dangi-Garimella, PhD
Researchers from Mexico recommend conducting a pulmonary function test in patients with non–small cell lung cancer (NSCLC) undergoing concurrent chemoradiotherapy to assess their susceptibility to developing radiation pneumonitis.
Dr Oliver Dorigo on Identified Biomarkers in Gynecologic Malignancies
April 25th 2018

Dr Oliver Dorigo on Identified Biomarkers in Gynecologic Malignancies

We have a number of biomarkers that we have shown are associated with a better response to certain new therapies, said Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
Site Logo
April 25th 2018

Evidence-Based OncologyTM Looks at Changing Ways to Pay for Cancer Care

The current issue of Evidence-Based Oncology™, a publication of The American Journal of Managed Care®, examines how new reimbursement models are making cancer care more patient-centered, but making those models sustainable is challenging.
Site Logo
April 24th 2018

From the Editor in Chief: A Game of Risk

Joseph Alvarnas, MD
Dr Alvarnas is editor-in-chief and director of Value-Based Analytics at City of Hope, Duarte, California.
Science 37, VisualDx Form Partnership to Help Guide Decision Making in Managing Skin Conditions
April 24th 2018

Science 37, VisualDx Form Partnership to Help Guide Decision Making in Managing Skin Conditions

AJMC Staff
The partnership will aid patients in an era of high-deductible health plans, which call on patients to make more of their own healthcare decisions.
New Test Could Make Multiple Myeloma Diagnosis as Easy as Drawing a Blood Sample
April 23rd 2018

New Test Could Make Multiple Myeloma Diagnosis as Easy as Drawing a Blood Sample

Laura Joszt, MA
A new blood test could negate the need for bone biopsies to diagnose a variety of cancers, including multiple myeloma. The test uses a small, low-cost plastic chip that delivers the same diagnostic information of a biopsy through a simple blood draw.
Site Logo
April 23rd 2018

Medical World News: Managed Care Updates

ASCO reviews clinical pathways; Flatiron Health acquired
Site Logo
April 23rd 2018

Dr Ray Page Discusses the Surprise of the First OCM Results

Laura Joszt, MA
Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders and chair-elect of the American Society of Clinical Oncology’s (ASCO) Clinical Practice Committee discusses the first results of the Oncology Care Model (OCM) and ASCO’s top legislative priorities.
Podcast: This Week in Managed Care—Bill Addresses Opioid Epidemic and Other Health News
April 21st 2018

Podcast: This Week in Managed Care—Bill Addresses Opioid Epidemic and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
Site Logo
April 21st 2018

Dr Houston Holmes Discusses CAR T Therapy Adoption and Education

Laura Joszt, MA
With chimeric antigen receptor (CAR) T-cell therapy being so new, there is going to be a learning curve as providers become more educated about the treatments, the manufacturing process, and the toxicities, Houston Holmes, MD, MBA, FACP, a medical oncologist with Texas Oncology, explained at the Community Oncology Alliance’s (COA) 2018 Community Oncology Conference.
Top 5 Developments and Concerns of Community Oncology Practices
April 21st 2018

Top 5 Developments and Concerns of Community Oncology Practices

Surabhi Dangi-Garimella, PhD
Reimbursement models, novel gene therapy–based treatments, and price transparency: these were some of the topics covered by presenters and panelists at the annual meeting of the Community Oncology Alliance.
Dr Martha Gaines: Turning Experience as Cancer Survivor into Patient Advocacy
April 20th 2018

Dr Martha Gaines: Turning Experience as Cancer Survivor into Patient Advocacy

Martha Gaines, MD, JD, LLM, founder and director of The Center for Patient Partnerships, clinical professor of law, University of Wisconsin Law School, explains how she turned her experience as a cancer survivor into a model for consumer-centered patient advocacy.
This Week in Managed Care: April 20, 2018
April 20th 2018

This Week in Managed Care: April 20, 2018

This week, the top managed care stories included a new bill in Congress to tackle the opioid epidemic; an analysis that warns against including drug costs in bundled payment models; the FDA commissioner shares ideas to improve innovation and access to next-generation sequencing.
Dr Joe O'Sullivan: Numerous Prostate Cancer Therapies Is a Challenge for Clinical Trials
April 19th 2018

Dr Joe O'Sullivan: Numerous Prostate Cancer Therapies Is a Challenge for Clinical Trials

Having numerous therapies to treat prostate cancer can actually be a bad thing—it makes it difficult to design clinical trials for new therapies coming into the space, explained Joe O'Sullivan, MD, FRCR, clinical professor, School of Medicine, Dentistry and Biomedical Sciences, Queen's University Belfast.
What We're Reading: Public Insurance Option; Puerto Rico's Health Challenges; Melanoma Survival in Married People
April 19th 2018

What We're Reading: Public Insurance Option; Puerto Rico's Health Challenges; Melanoma Survival in Married People

AJMC Staff
A group of Democrats unveil a bill to set up a new public health insurance option; a look at the health challenges that persist in Puerto Rico after Hurricane Maria; married people are more likely to get diagnosed early and be treated in a timely fashion for melanoma.
Novel Drug Shows Promise in Acute Myeloid Leukemia by Suppressing Two Proteins
April 19th 2018

Novel Drug Shows Promise in Acute Myeloid Leukemia by Suppressing Two Proteins

Laura Joszt, MA
A novel drug that targets MDMX and MDM2, which inhibit a protein that suppresses tumors when they are overexpressed, has tripled the median survival rate in an animal model of human acute myeloid leukemia, according to new research.
Dr Sean C. Dowdy Discusses Improving Surgical Outcomes in Gynecologic Oncology
April 18th 2018

Dr Sean C. Dowdy Discusses Improving Surgical Outcomes in Gynecologic Oncology

Early feeding, euvalemia, and multimodal pain management can be used to to accelerate surgical recovery and improve outcomes in gynecologic oncology, explained Sean C. Dowdy, MD, chair, division of gynecologic surgery, department of obstetrics and gynecology, Mayo Clinic.
Site Logo
April 18th 2018

Conference Coverage: Association of Community Cancer Centers

Coverage from the Association of Community Cancer Centers’ 44th Annual Meeting & Cancer Center Business Summit, March 14-16, 2018, in Washington, DC.
Dr Thomas LeBlanc on the Importance of Shared Decision Making in Cancer Care
April 18th 2018

Dr Thomas LeBlanc on the Importance of Shared Decision Making in Cancer Care

Thomas LeBlanc, MD, of the Duke Cancer Institute, addresses the importance of adding a palliative care specialist to the cancer care team.
Patients With HIV Face Increased Risk of Mortality From Lung Cancer
April 18th 2018

Patients With HIV Face Increased Risk of Mortality From Lung Cancer

Kelly Davio
The increased risk of cancer in patients with HIV has been well defined, and some studies have suggested that patients with HIV have not only a higher risk of lung cancer, but also an increased risk of mortality from their cancer than patients without HIV.
Bundled Payments That Include Drug Costs Would Penalize Practices Based on Patient Mix
April 18th 2018

Bundled Payments That Include Drug Costs Would Penalize Practices Based on Patient Mix

Laura Joszt, MA
An analysis of a hypothetical bundled payment that included drug costs would unfairly penalize practices based on patient mix and could destabilize the cancer care delivery environment, according to research published in the Journal of Oncology Practice.
Site Logo
April 17th 2018

Conference Coverage: ASCO Genitourinary Cancers Symposium

Coverage from the American Society of Clinical Oncology Genitourinary Cancers Symposium, held February 8-10, 2018, in San Francisco, California
Michele McCourt on Potential New Therapies for Patients With Cancer
April 17th 2018

Michele McCourt on Potential New Therapies for Patients With Cancer

The high cost of new, innovative cancer treatments coming to market makes these therapies inaccessible to a lot of patients, said Michele McCourt, senior director of the CancerCare Co-Payment Assistance Foundation.
Site Logo
April 17th 2018

The Well-Being of Long-Term Cancer Survivors

Jeffrey Sullivan, MS Julia Thornton Snider, PhD Emma van Eijndhoven, MS, MA Tony Okoro, PharmD, MPH Katharine Batt, MD, MSc Thomas DeLeire, PhD
This study compares the well-being of long-term cancer survivors with that of US residents of similar age and demographic characteristics, patients recently diagnosed with cancer, and individuals with chronic illness.
Identification of Genes Involved With MM Development Could Mean More Personalized Treatments
April 16th 2018

Identification of Genes Involved With MM Development Could Mean More Personalized Treatments

Laura Joszt, MA
The identification of 40 genes involved with the development of multiple myeloma could lead to the development of more personalized treatments.
<1
...
484950515253545556
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo